Eris Lifesciences planning to raise funds

17 May 2024 Evaluate

Eris Lifesciences is planning to raise funds by issuance of Non-Convertible Securities, through permissible modes under applicable law and subject to such regulatory/ statutory approvals, as may be required. The meeting of Board of Directors of the company is scheduled to be held on May 21, 2024, to consider and approve the same.

Eris Lifesciences develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives.


Eris Lifesciences Share Price

915.60 2.65 (0.29%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.